# Mesenchymal stem cell therapy for severe COVID-19

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mesenchymal-stem-cell-therapy-for-severe-covid-19/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lei Shi,Lifeng Wang,Ruonan Xu,Chao Zhang,Yunbo Xie,Kai Liu,Tiantian Li,Wei Hu,Cheng Zhen,Fu‐Sheng Wang |
| Citations | 135 |
| DOI | 10.1038/s41392-021-00754-6 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/s41392-021-00754-6.pdf |
| OpenAlex ID | https://openalex.org/W3196776352 |
| PMID | 34497264 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Tiantian Li](https://scholariq.org/researchers/tiantian-li/)

## Paper journal

- [Signal Transduction and Targeted Therapy](https://scholariq.org/journals/signal-transduction-and-targeted-therapy/)

## Paper primary topic

- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)

## Paper topics

- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.